Parathyroid hormone and noradrenaline-induced enhancement of cyclic AMP in a cloned osteogenic sarcoma cell line (UMR 106) is inhibited by neuropeptide Y.
Bjurholm
A
A
Department of Orthopaedic Surgery, Karolinska Hospital, Stockholm, Sweden.
Kreicbergs
A
A
Schultzberg
M
M
Lerner
U H
UH
D000818:Animals; D002461:Cell Line, Transformed; D000242:Cyclic AMP / Q000096:biosynthesis*; D006801:Humans; D009478:Neuropeptide Y / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology*; D010006:Osteoblasts / Q000378:metabolism; D012516:Osteosarcoma / Q000378:metabolism*; D010281:Parathyroid Hormone / Q000494:pharmacology*; D017476:Receptors, Neuropeptide Y; D017981:Receptors, Neurotransmitter / Q000187:drug effects
D009478:Neuropeptide Y; D010281:Parathyroid Hormone; D017476:Receptors, Neuropeptide Y; D017981:Receptors, Neurotransmitter; D000242:Cyclic AMP; D009638:Norepinephrine